InvestSMART

Carnegie Clean Energy Limited (ASX: CCE) - Announcements

Current share price for CCE : $0.225 0.02 (9.76%)+

ASX company news and announcements for Carnegie Clean Energy Limited (CCE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Carnegie Clean Energy Limited (CCE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Carnegie Clean Energy Limited (CCE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Carnegie Clean Energy Limited (CCE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$93 Commitments Test Entity - Second Quarter Report 30 Jan 2007 8:30AM $0.130 $0.225 risen by 73.08%
$93 SPP Oversubscribed & Additional Placement 7 Dec 2006 8:30AM $0.115 $0.225 risen by 95.65%
$93 Update on US approval for ReCell 27 Nov 2006 8:30AM $0.135 $0.225 risen by 66.67%
$93 Response to ASX Query re: Share Price 23 Nov 2006 3:44PM $0.135 $0.225 risen by 66.67%
$93 ReCell Clinical Update 14 Nov 2006 8:30AM $0.092 $0.225 risen by 144.57%
$93 CellSpray approved in Greece 8 Nov 2006 8:29AM $0.085 $0.225 risen by 164.71%
$93 Commitments Test Entity - First Quarter Report 31 Oct 2006 8:28AM $0.084 $0.225 risen by 167.86%
$93 Underwritten Share Purchase Plan 25 Oct 2006 9:38AM $0.088 $0.225 risen by 155.68%
$93 Supply Agreement 28 Sep 2006 8:30AM $0.097 $0.225 risen by 131.96%
$93 Preliminary Final Report 7 Sep 2006 8:29AM $0.096 $0.225 risen by 134.38%
$93 Commitments Test Entity - Fourth Quarter Report 27 Jul 2006 8:29AM $0.115 $0.225 risen by 95.65%
$93 ReCell Approved in Canada 27 Jun 2006 8:32AM $0.115 $0.225 risen by 95.65%
$93 TGA Approves ReCell 25 May 2006 8:29AM $0.140 $0.225 risen by 60.71%
$93 Commitments Test Entity - Third Quarter Report 26 Apr 2006 8:31AM $0.165 $0.225 risen by 36.36%
$93 TGA Recommends 'ReCell' for Approval 3 Apr 2006 8:30AM $0.175 $0.225 risen by 28.57%
$93 Corporate Update/Sales Forecasts 15 Mar 2006 12:12PM $0.145 $0.225 risen by 55.17%
$93 Half Yearly Report & Half Year Accounts 3 Mar 2006 8:30AM $0.180 $0.225 risen by 25%
$93 Commitments Test Entity - Second Quarter Report 30 Jan 2006 8:30AM $0.210 $0.225 risen by 7.14%
$93 Regulatory Update on ReCell - FDA & TGA 16 Jan 2006 8:29AM $0.220 $0.225 risen by 2.27%
$93 Update on ReCell TGA Approval in Australia 21 Dec 2005 8:30AM $0.200 $0.225 risen by 12.50%
$93 Response to ASX Share Price Query 9 Dec 2005 12:32PM $0.300 $0.225 fallen by 25%
$93 Appointment of Distributors in Russia & Slovakia 28 Nov 2005 8:30AM $0.355 $0.225 fallen by 36.62%
$93 Appointment of Chinese Distributor 23 Nov 2005 8:31AM $0.370 $0.225 fallen by 39.19%
$93 CellSpray Production Partner for Korea 4 Nov 2005 8:30AM $0.370 $0.225 fallen by 39.19%
$93 Commitments Test Entity - First Quarter Report 28 Oct 2005 8:29AM $0.340 $0.225 fallen by 33.82%

576 - 600 of 627 results

Page 24 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.